Galapagos NV (GLPG) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Galapagos NV (GLPG) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 2, 2023 (13:52)

Sector: Healthcare

The share price of Galapagos NV (GLPG) now

What analysts predict: $44.71
52-week High/Low: $48.07 / $31.86

50/200 Day Moving Average: $35.34 / $38.67

This figure corresponds to the Average Price over the previous 50/200 days. For Galapagos NV stocks, the 50-day moving average is the support level today.

For Galapagos NV stocks, the 200-day moving average is the resistance level today.

Are you interested in Galapagos NV stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galapagos NV stock price in 2024, 2025, 2026, 2027, 2028. How much will one Galapagos NV share be worth in 2024 - 2028?

When should I take profit in Galapagos NV stock? When should I record a loss on Galapagos NV stock? What are analysts' forecasts for Galapagos NV stock? What is the future of Galapagos NV stock? We forecast Galapagos NV stock performance using neural networks based on historical data on Galapagos NV stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Galapagos NV stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Galapagos NV shares. This happens once a day.




Historical and forecast chart of Galapagos NV stock

The chart below shows the historical price of Galapagos NV stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galapagos NV stock price can be found in the table below.

Long-term forecasts by years.

Galapagos NV, a clinical stage biotechnology company, discovers, develops and markets various small molecule drugs. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren’s syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, membranous nephropathy lupus and uveitis.

Galapagos NV daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 04 37.56 36.69 38.22 4.16
Dec 05 36.97 36.29 37.86 4.31
Dec 06 36.35 35.88 36.86 2.73
Dec 07 36.78 36.03 37.80 4.89
Dec 08 37.41 36.85 38.13 3.48
Dec 09 37.16 36.76 37.73 2.65
Dec 10 37.46 36.90 37.76 2.35
Dec 11 37.76 37.29 38.38 2.94
Dec 12 37.46 36.59 37.81 3.33
Dec 13 36.70 35.97 36.98 2.82
Dec 14 36.62 35.71 37.39 4.70
Dec 15 37.47 36.72 37.82 3.00
Dec 16 37.79 37.12 38.14 2.74
Dec 17 38.36 37.66 39.26 4.24
Dec 18 37.99 37.57 38.85 3.40
Dec 19 38.76 38.41 39.38 2.54
Dec 20 39.31 38.60 39.85 3.24
Dec 21 38.89 38.34 39.46 2.91
Dec 22 38.17 37.19 39.21 5.42
Dec 23 37.14 36.11 38.05 5.36
Dec 24 36.77 35.86 37.06 3.34
Dec 25 35.50 34.95 36.24 3.70
Dec 26 36.11 35.53 36.66 3.20
Dec 27 37.27 36.32 37.79 4.06
Dec 28 36.80 36.13 37.55 3.92
Dec 29 37.07 36.64 37.60 2.62
Dec 30 37.47 36.62 38.52 5.19
Dec 31 36.24 35.45 36.91 4.11
Jan 01 34.97 34.34 35.92 4.60
Jan 02 35.16 34.53 35.67 3.31

Galapagos NV Daily Price Targets


Galapagos NV Stock Forecast 12-04-2023.

Forecast target price for 12-04-2023: $37.56.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 3.990%.
Pessimistic target level: 36.69
Optimistic target level: 38.22

Galapagos NV Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $36.97.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 4.135%.
Pessimistic target level: 36.29
Optimistic target level: 37.86

Galapagos NV Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $36.35.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 2.658%.
Pessimistic target level: 35.88
Optimistic target level: 36.86

Galapagos NV Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $36.78.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 4.666%.
Pessimistic target level: 36.03
Optimistic target level: 37.80

Galapagos NV Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $37.41.
Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.365%.
Pessimistic target level: 36.85
Optimistic target level: 38.13

Galapagos NV Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $37.16.
Negative dynamics for Galapagos NV shares will prevail with possible volatility of 2.585%.
Pessimistic target level: 36.76
Optimistic target level: 37.73

GLPG (GLPG) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan. 43.12 39.39 45.12 12.69
Feb. 49.40 46.63 55.01 15.23
Mar. 51.61 49.88 57.31 12.97
Apr. 51.53 45.26 57.05 20.66
May. 48.07 43.91 53.99 18.66
Jun. 55.45 48.44 60.51 19.94
Jul. 58.55 53.31 61.08 12.73
Aug. 62.39 56.80 65.99 13.92
Sep. 59.50 54.17 65.69 17.54
Oct. 62.64 59.83 66.45 9.95
Nov. 62.84 56.71 70.38 19.43
Dec. 60.73 55.68 65.39 14.86

Galapagos NV forecast for this year


Galapagos NV Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $43.1194. Pessimistic: $39.39. Optimistic: $45.12


Galapagos NV Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $49.3975. Pessimistic: $46.63. Optimistic: $55.01


Galapagos NV Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $51.6105. Pessimistic: $49.88. Optimistic: $57.31


Galapagos NV Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $51.528. Pessimistic: $45.26. Optimistic: $57.05


Galapagos NV Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $48.0653. Pessimistic: $43.91. Optimistic: $53.99


Galapagos NV Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $55.4481. Pessimistic: $48.44. Optimistic: $60.51


Galapagos NV Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $58.5532. Pessimistic: $53.31. Optimistic: $61.08


Galapagos NV Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $62.3943. Pessimistic: $56.80. Optimistic: $65.99


Galapagos NV Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $59.4992. Pessimistic: $54.17. Optimistic: $65.69


Galapagos NV Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $62.6408. Pessimistic: $59.83. Optimistic: $66.45


Galapagos NV Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $62.8412. Pessimistic: $56.71. Optimistic: $70.38


Galapagos NV Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $60.7298. Pessimistic: $55.68. Optimistic: $65.39



Galapagos NV (GLPG) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 58.11 52.62 61.27 14.11
Feb 61.92 56.27 66.08 14.84
Mar 64.59 61.91 67.18 7.85
Apr 68.00 59.52 74.64 20.26
May 73.77 64.33 76.37 15.76
Jun 71.53 67.29 79.77 15.64
Jul 79.65 72.39 84.37 14.20
Aug 83.99 79.55 91.24 12.81
Sep 87.08 76.49 91.81 16.69
Oct 82.48 71.92 92.64 22.36
Nov 84.46 80.67 90.54 10.90
Dec 88.92 78.67 99.02 20.55

Galapagos NV (GLPG) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 96.60 92.89 107.27 13.40
Feb 98.76 90.07 105.88 14.93
Mar 113.14 103.01 127.63 19.29
Apr 108.62 99.23 119.92 17.25
May 103.23 94.81 114.96 17.53
Jun 104.39 98.37 111.07 11.43
Jul 96.04 90.81 101.88 10.86
Aug 94.35 86.50 105.37 17.91
Sep 100.84 93.74 112.62 16.76
Oct 105.36 94.73 115.97 18.31
Nov 119.01 110.25 128.15 13.97
Dec 127.77 119.80 139.01 13.82

Galapagos NV (GLPG) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 147.39 129.94 166.26 21.84
Feb 140.79 134.71 151.60 11.14
Mar 141.02 129.51 153.42 15.59
Apr 121.16 111.08 125.62 11.57
May 107.78 102.78 119.17 13.75
Jun 116.23 101.73 120.51 15.59
Jul 116.42 111.02 121.82 8.87
Aug 130.76 115.70 139.76 17.22
Sep 147.29 140.93 161.90 12.95
Oct 151.30 140.89 162.92 13.52
Nov 158.08 140.12 168.19 16.69
Dec 160.10 152.93 177.26 13.73

Galapagos NV (GLPG) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 149.34 130.70 163.92 20.26
Feb 143.37 127.31 154.38 17.53
Mar 164.93 147.25 175.49 16.09
Apr 158.60 139.57 170.78 18.28
May 148.95 142.52 157.53 9.53
Jun 155.39 146.44 169.81 13.76
Jul 145.20 127.54 155.18 17.81
Aug 151.24 135.51 164.30 17.53
Sep 164.06 149.10 172.72 13.68
Oct 168.26 151.03 176.07 14.22
Nov 167.72 156.72 188.12 16.69
Dec 189.46 179.76 196.13 8.35

Galapagos NV information and performance

Galapagos NV Address

GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE

Market Capitalization: 2 448 043 000 $

Market capitalization of the Galapagos NV is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GLPG shares in the company outstanding by the market price of one share.

EBITDA: -139 347 008 $

EBITDA of Galapagos NV is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.56

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.19
Quarterly Revenue Growth YOY: -0.119
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 81.3

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.184

Enterprise Value (EV) /Revenue

EV To EBITDA: 12.15

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 65897000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.